StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
CDNA

CareDx, Inc.

CDNA Nasdaq Services-Medical Laboratories EDGAR ↗
$47.85
+9.75 +25.59%

Key statistics

from XBRL data in SEC filings
Market cap
$2.48B
Revenue (TTM)
$458M
Net income (TTM)
$111M
EPS (TTM)
$2.07
P/E ratio
23.1
Dividend yield
Free cash flow
$40.0M
Cash
$374M
Total assets
$533M
Gross margin
21.4%
52-week range
$11.26 – $49.76

Recent SEC filings

40 most recent
Annual, quarterly & current reports
10-Q Quarter ended 2026-06-30 Jul 30, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jul 30, 2026 8-K Completed an acquisition or disposition; Regulation FD disclosure Jul 7, 2026 8-K Director or officer change; Shareholder vote results Jun 15, 2026 10-Q Quarter ended 2026-03-31 Apr 28, 2026 8-K Entered a material agreement; Results of operations (earnings release); Regulation FD disclosure; Other events Apr 28, 2026 8-K/A Director or officer change Apr 23, 2026 8-K Entered a material agreement; Results of operations (earnings release); Regulation FD disclosure Apr 16, 2026 8-K/A Results of operations (earnings release); Director or officer change; Regulation FD disclosure Feb 25, 2026 10-K Fiscal year ended 2025-12-31 Feb 25, 2026 8-K Results of operations (earnings release) Feb 24, 2026 8-K Results of operations (earnings release) Jan 12, 2026 8-K Other events Dec 18, 2025 8-K Amended charter or bylaws Dec 15, 2025 10-Q Quarter ended 2025-09-30 Nov 4, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 4, 2025 8-K Director or officer change Oct 24, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Results of operations (earnings release); Director or officer change; Regulation FD disclosure Aug 6, 2025 8-K Director or officer change; Shareholder vote results Jun 12, 2025 8-K Regulation FD disclosure; Other events Jun 3, 2025 10-Q Quarter ended 2025-03-31 Apr 30, 2025 8-K Results of operations (earnings release) Apr 30, 2025 8-K Director or officer change Mar 28, 2025 10-K Fiscal year ended 2024-12-31 Feb 28, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Feb 26, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jan 13, 2025 8-K Director or officer change Jan 8, 2025 10-Q Quarter ended 2024-09-30 Nov 4, 2024 8-K Results of operations (earnings release) Nov 4, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Oct 15, 2024 8-K Other events Oct 8, 2024 8-K Director or officer change Oct 4, 2024 8-K Director or officer change; Other events Sep 12, 2024 10-Q Quarter ended 2024-06-30 Jul 31, 2024 8-K Results of operations (earnings release) Jul 31, 2024 8-K Shareholder vote results Jun 18, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 9, 2024 8-K Director or officer change; Other events Apr 16, 2024